It is generally accepted that conventional imaging techniques have limitations in their ability to differentiate benign and malignant disease processes resulting in bone destruction. Although computed tomography (CT) has proved helpful in the diagnosis of such lesions in the paranasal sinuses, the underlying radiological criteria are unclear and the value of contrast enhancement appears limited. Conventional radiographs and CT scans, with dynamic contrast infusion, from five patients in whom a provisional diagnosis of antral carcinoma had been made were reviewed in the light of a subsequent histopathological diagnosis of benign inflammatory disease. In four of these patients, a band of enhancement was demonstrated to parallel the antral walls which, in three cases, remained intact despite underlying bony defects. Their finding is significant in that it demonstrates mucosal integrity, thus making the radiological diagnosis of antral carcinoma less attractive and allowing assessment of the extent of inflammatory soft tissue changes. Thus the use of contrast-enhanced CT is recommended in the assessment of patients in whom sinus disease with bone destruction has been identified on conventional radiographic examination.
The aim of this book is simple: to aid candidates preparing for the final fellowship examination of the Royal College of Radiologists. In particular, it is designed to simulate the format of the radiograph viewing session. To succeed in this aim any book must fulfil several requirements. A wide range of subjects should be covered, extending from the common to the rare, using different imaging techniques.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.